| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 0.4728 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 0.485 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 0.7168 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 0.7285 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 0.9454 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 1 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 1.0314 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 1.184 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 1.2062 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 1.3448 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | azelate (C9-DC) | 1.7724 | Relative Abundance | CON |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|